The Bioimaging Core
生物成像核心
基本信息
- 批准号:10612971
- 负责人:
- 金额:$ 21.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-30 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAnimalsBasic ScienceBioinformaticsBiologyCell Culture TechniquesCell physiologyCellsCellular StructuresCellular biologyChemistryClinicalCollaborationsComplexDataDevelopmentDigestive PhysiologyDigestive System DisordersDiseaseDoctor of PhilosophyEducationEducational workshopEmerging TechnologiesEngineeringEnsureEpithelial CellsEpitheliumEvaluationFeedbackFeesFibroblastsFibrosisFluorescenceFluorescence MicroscopyFundingFutureGastrointestinal MotilityGoalsHealthHerbert Irving Comprehensive Cancer CenterHistologyHomeostasisHumanHuman ResourcesImageImaging DeviceImaging technologyImmuneIn VitroIndividualInflammationInterventionLaboratoriesLeadershipLinkLipidsLiver diseasesMagnetic Resonance ImagingMeasurementMicrobeMicroscopeMicroscopyMissionMusNatural regenerationNeoplasmsNerveOlives - dietaryOpticsOrganOrganizational EfficiencyOrganoidsPeptidesPharmaceutical PreparationsProteinsProtocols documentationQualifyingQuality ControlResearchResearch PersonnelResearch SupportResolutionResource SharingResourcesScienceScientistServicesSignal PathwaySpecimenSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSurveysTechnologyTimeTissuesTrainingTraining and EducationUnited States National Institutes of HealthUniversitiesX-Ray Computed Tomographyanimal imagingbioimagingcell motilityclinical imagingcostexperiencefluorescence imaginghigh resolution imaginghuman imagingimaging capabilitiesimaging modalityimaging platformin vivoin vivo imaginginnovationinnovative technologiesinstrumentationmass spectrometric imagingmembermicroCTmicrobiotamulti-photonmultimodal datamultiple datasetsnanometernew technologynoveloperationoptical imagingpatient derived xenograft modelprogramsreflectance confocal microscopyresponsesingle cell analysissingle-cell RNA sequencingsuccesssuperresolution microscopytechnology platformtooltranscriptomicsultra high resolutionultrasound
项目摘要
SUMMARY
The Bioimaging Core (BIC) in the Columbia University Digestive and Liver Disease Research Center (CU-
DLDRC) will make essential contributions for the understanding and treatment of digestive diseases. State-of-
the-art imaging can resolve the complex interactions between cells, organs, metabolites and microbiota that
regulate digestive health and disease. However, the cost and expertise of maintaining and operating complex
imaging platforms are beyond the financial and technical means of most individual laboratories. The overall goal
of the BIC is to provide CU-DLDRC members with state-of-the-art imaging platforms to study mechanisms of
digestive health and disease in small animals and human biospecimens in vitro and in vivo, providing resolutions
ranging from nanometers to centimeters. The BIC is organized into two units with high-end digestive-focused
imaging capabilities backed by expert technical assistance, each led by a highly qualified director with
longstanding experience in imaging and core administration. The Microscopy Unit, overseen by BIC Co-Director
Liza Pon, provides access to a sophisticated suite of microscopes, including single, multiphoton and spinning
disk confocal, super-resolution and total internal reflection fluorescence microscopy, which allow rapid and high-
resolution imaging of living or fixed digestive tissue specimens. The Small Animal Imaging Unit, overseen by BIC
director Ken Olive, provides access to high-end magnetic resonance imaging, ultrasound, X-ray computed
tomography, and optical imaging instruments for imaging of digestive organs and their functions in small animals.
In addition, the BIC will develop new digestive-focused imaging modalities, including (i) imaging mass
spectrometry with CU-DLDRC member Brent Stockwell for high resolution imaging of metabolites in digestive
tissue; and (ii) SCAPE imaging, a novel meso-scale optical platform based on endogenous tissue fluorescence,
engineered by CU-DLDRC member Elizabeth Hillman. The Small Animal Imaging unit will also develop novel
applications specific for the assessment of gastrointestinal motility, fibrosis, inflammation, tracking of engineered
microbes, and in vivo measurement of metabolites. The BIC will contribute to the overall mission of the CU-
DLDRC through the following interrelated Aims: To analyze cellular structures and processes that regulate
epithelial health in digestive tissues via microscopy (Aim 1); to provide in vivo small animal imaging technologies
for the study of digestive physiology and disease (Aim 2); and to provide hands-on training and education in
advanced digestive imaging applications (Aim 3). BIC will be a highly utilized resource with 43 out of the 49 CU-
DLDRC members (88%) planning to use its services. Via multicore workflows, BIC will closely link to the other
CU-DLDRC biomedical cores, thus providing CU-DLDRC members with easy access to imaging clinical
biospecimens and organoids, or combining their imaging with advanced bioinformatics analyses. In sum, BIC
will benefit the research of basic and clinical CU-DLDRC members and provide significant value added.
概括
哥伦比亚大学消化和肝脏疾病研究中心 (CU-
DLDRC)将为消化系统疾病的理解和治疗做出重要贡献。状态-
最先进的成像技术可以解决细胞、器官、代谢物和微生物群之间复杂的相互作用
调节消化系统健康和疾病。然而,维护和运营复杂的成本和专业知识
成像平台超出了大多数个体实验室的财务和技术能力。总体目标
BIC 的目标是为 CU-DLDRC 成员提供最先进的成像平台来研究
小动物和人类生物样本的体外和体内消化健康和疾病,提供解决方案
范围从纳米到厘米。 BIC 分为两个单元,以高端消化为重点
成像能力得到专家技术协助的支持,每一位技术协助均由一位高素质的主管领导
在成像和核心管理方面拥有长期经验。显微镜科,由 BIC 联合主任监督
Liza Pon,提供了一套复杂的显微镜,包括单光子、多光子和旋转显微镜
圆盘共焦、超分辨率和全内反射荧光显微镜,可实现快速、高精度
活体或固定消化组织标本的分辨率成像。小动物成像中心,由 BIC 监管
总监 Ken Olive,提供高端磁共振成像、超声波、X 射线计算
断层扫描和光学成像仪器,用于对小动物的消化器官及其功能进行成像。
此外,BIC 将开发新的消化聚焦成像模式,包括 (i) 质量成像
与 CU-DLDRC 成员 Brent Stockwell 合作进行光谱测定,对消化道中的代谢物进行高分辨率成像
组织; (ii) SCAPE 成像,一种基于内源组织荧光的新型介观光学平台,
由 CU-DLDRC 成员 Elizabeth Hillman 设计。小动物成像装置也将开发新颖的
专门用于评估胃肠道运动、纤维化、炎症、跟踪工程化的应用
微生物和代谢物的体内测量。 BIC 将为 CU 的总体使命做出贡献
DLDRC 通过以下相互关联的目标: 分析调节细胞结构和过程
通过显微镜观察消化组织上皮的健康状况(目标 1);提供小动物活体成像技术
用于消化生理学和疾病的研究(目标 2);并提供实践培训和教育
先进的消化成像应用(目标 3)。 BIC 将成为一种高度利用的资源,49 个 CU 中有 43 个
DLDRC 成员 (88%) 计划使用其服务。通过多核工作流程,BIC 将与其他工作流程紧密相连
CU-DLDRC 生物医学核心,从而为 CU-DLDRC 成员提供轻松访问影像临床的机会
生物样本和类器官,或将其成像与先进的生物信息学分析相结合。总而言之,BIC
将有利于 CU-DLDRC 成员的基础和临床研究,并提供显着的附加值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kenneth P Olive其他文献
Kenneth P Olive的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kenneth P Olive', 18)}}的其他基金
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
- 批准号:
10590731 - 财政年份:2017
- 资助金额:
$ 21.65万 - 项目类别:
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
- 批准号:
10088424 - 财政年份:2017
- 资助金额:
$ 21.65万 - 项目类别:
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
- 批准号:
9289422 - 财政年份:2017
- 资助金额:
$ 21.65万 - 项目类别:
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
- 批准号:
10446758 - 财政年份:2017
- 资助金额:
$ 21.65万 - 项目类别:
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
胰腺癌平滑抑制的基质反应机制
- 批准号:
8591387 - 财政年份:2011
- 资助金额:
$ 21.65万 - 项目类别:
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
胰腺癌平滑抑制的基质反应机制
- 批准号:
8084639 - 财政年份:2011
- 资助金额:
$ 21.65万 - 项目类别:
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
胰腺癌平滑抑制的基质反应机制
- 批准号:
8403907 - 财政年份:2011
- 资助金额:
$ 21.65万 - 项目类别:
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
胰腺癌平滑抑制的基质反应机制
- 批准号:
8232091 - 财政年份:2011
- 资助金额:
$ 21.65万 - 项目类别:
相似国自然基金
乳酸介导的组蛋白乳酸化调控哺乳动物主要合子基因组激活的机制研究
- 批准号:82301880
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
早期环境暴露对儿童哮喘免疫保护的动物实验和机制研究
- 批准号:82300031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带森林土壤氮添加下微节肢动物对氮转化过程的调控
- 批准号:32360323
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Slc39a13在哺乳动物铁代谢中的作用
- 批准号:32371226
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 21.65万 - 项目类别:
Engineering Human Organizer To Study Left-Right Symmetry Breaking
工程人类组织者研究左右对称性破缺
- 批准号:
10667938 - 财政年份:2023
- 资助金额:
$ 21.65万 - 项目类别:
Ex vivo whole ovary culture system for screening gonadotoxicity during drug development
用于在药物开发过程中筛选性腺毒性的离体全卵巢培养系统
- 批准号:
10823136 - 财政年份:2023
- 资助金额:
$ 21.65万 - 项目类别:
Commercial translation of high-density carbon fiber electrode arrays for multi-modal analysis of neural microcircuits
用于神经微电路多模态分析的高密度碳纤维电极阵列的商业转化
- 批准号:
10761217 - 财政年份:2023
- 资助金额:
$ 21.65万 - 项目类别:
Modernization of 3-dimensional printing capabilities at the Aquatic Germplasm and Genetic Resource Center
水产种质和遗传资源中心 3 维打印能力的现代化
- 批准号:
10736961 - 财政年份:2023
- 资助金额:
$ 21.65万 - 项目类别: